Aptiv Releases Q3 2026 Results; Investment Thesis Unchanged Pending Details

What happened

Aptiv reported its third quarter 2026 results on November 3, 2026, with details available in the earnings release and a management conference call scheduled for 8:00 AM ET. The results are the first quarterly update following the planned EDS spin-off expected in early 2026, and investors will scrutinize progress on margin expansion and growth in the new Aptiv structure. The DeepValue master report rated the stock a potential buy with a base case of $90, driven by successful execution of the spin and continued margin improvement. Key metrics to watch include revenue growth, adjusted EBITDA margin, and cash flow, as well as any updates on the spin-off timeline and leverage. Today's announcement provides no quantitative details, so the investment thesis remains unchanged pending review of the full release and conference call commentary.

Implication

The Q3 2026 results will either validate the thesis that New Aptiv can deliver 4-7% growth and margin expansion despite tariff headwinds, or signal a need to reassess. If the spin-off has closed and standalone metrics align with guidance, the stock could re-rate toward the base case of $90. Conversely, any delay or margin miss would increase downside risk toward $65. Investors should focus on adjusted EBITDA margin, free cash flow, and any commentary on non-auto and software growth. The conference call today may provide crucial qualitative insights into management's confidence in the 2028 targets.

Thesis delta

No change to the investment thesis based on this announcement alone. The Q3 2026 results will provide the first hard data on whether the spin-off and margin expansion plan are on track. If results confirm execution, conviction increases; if not, we may downgrade.